DE69523733T2 - Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten - Google Patents

Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten

Info

Publication number
DE69523733T2
DE69523733T2 DE69523733T DE69523733T DE69523733T2 DE 69523733 T2 DE69523733 T2 DE 69523733T2 DE 69523733 T DE69523733 T DE 69523733T DE 69523733 T DE69523733 T DE 69523733T DE 69523733 T2 DE69523733 T2 DE 69523733T2
Authority
DE
Germany
Prior art keywords
cellulose ethers
geling
disposal
thermally
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69523733T
Other languages
English (en)
Other versions
DE69523733D1 (de
Inventor
Bhagwati P Kabra
John C Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Application granted granted Critical
Publication of DE69523733D1 publication Critical patent/DE69523733D1/de
Publication of DE69523733T2 publication Critical patent/DE69523733T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
DE69523733T 1994-08-30 1995-08-23 Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten Expired - Lifetime DE69523733T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29824494A 1994-08-30 1994-08-30
PCT/US1995/010877 WO1996006597A1 (en) 1994-08-30 1995-08-23 Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers

Publications (2)

Publication Number Publication Date
DE69523733D1 DE69523733D1 (de) 2001-12-13
DE69523733T2 true DE69523733T2 (de) 2002-08-01

Family

ID=23149679

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69523733T Expired - Lifetime DE69523733T2 (de) 1994-08-30 1995-08-23 Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten

Country Status (15)

Country Link
US (1) US5618800A (de)
EP (1) EP0725628B1 (de)
JP (1) JPH09508143A (de)
CN (1) CN1162148C (de)
AT (1) ATE208186T1 (de)
AU (1) AU686455B2 (de)
CA (1) CA2172373C (de)
DE (1) DE69523733T2 (de)
DK (1) DK0725628T3 (de)
ES (1) ES2162638T3 (de)
HK (1) HK1012558A1 (de)
MX (1) MX9601591A (de)
PT (1) PT725628E (de)
TW (1) TW460288B (de)
WO (1) WO1996006597A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19746264A1 (de) * 1997-10-20 1999-04-29 Wolff Walsrode Ag Verfahren zur Herstellung einer Carboxymethylcellulose mit verbesserter Wasserretention
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
IL144084A0 (en) * 1999-02-03 2002-05-23 Biosante Pharmaceuticals Inc Therapeutic calcium phosphate particles and methods of manufacture and use
US6235893B1 (en) 1999-04-01 2001-05-22 The Dow Chemical Company Process for making cellulose ether having enhanced gel strength
EP1171471B2 (de) * 1999-04-01 2009-07-08 Dow Global Technologies Inc. Methylcellulose mit verbesserter gelfestigkeit
US7226407B2 (en) 1999-06-09 2007-06-05 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
US7121997B2 (en) 1999-06-09 2006-10-17 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
AU769863B2 (en) 1999-06-09 2004-02-05 Ethicon Inc. Method and apparatus for adjusting flexible areal polymer implants
US6932759B2 (en) 1999-06-09 2005-08-23 Gene W. Kammerer Surgical instrument and method for treating female urinary incontinence
PL354928A1 (en) 1999-11-01 2004-03-22 Alcon, Inc. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
US7097855B1 (en) 2000-01-31 2006-08-29 Massachusetts Institute Of Technology Transdermal thermal polymerization
US7131943B2 (en) 2000-03-09 2006-11-07 Ethicon, Inc. Surgical instrument and method for treating organ prolapse conditions
ES2225573T3 (es) 2000-07-28 2005-03-16 Alcon, Inc Composiciones farmaceuticas que contienen tobramicina y goma xantana.
WO2002040056A2 (en) 2000-11-06 2002-05-23 Alcon, Inc Carrageenan viscoelastics for ocular surgery
US20030060447A1 (en) * 2002-04-24 2003-03-27 Mutlu Karakelle Non-aspirating transitional viscoelastics for use in surgery
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
DE10224352A1 (de) * 2002-06-01 2003-12-11 Mueller Schulte Detlef Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
US7727549B2 (en) * 2002-07-15 2010-06-01 Alcon, Inc. Pharmaceutical compositions for otic use
DE10350248A1 (de) * 2003-10-28 2005-06-16 Magnamedics Gmbh Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
CA2586035A1 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
AU2006275350A1 (en) 2005-08-04 2007-02-08 C.R. Bard, Inc. Pelvic implant systems and methods
WO2007059199A2 (en) 2005-11-14 2007-05-24 C.R. Bard, Inc. Sling anchor system
US20070141091A1 (en) * 2005-12-21 2007-06-21 Erning Xia Biguanide ointment and method of treatment and prevention of infections
US20070142478A1 (en) * 2005-12-21 2007-06-21 Erning Xia Combination antimicrobial composition and method of use
US20070140897A1 (en) * 2005-12-21 2007-06-21 Hongna Wang Ph stable biguanide composition and method of treatment and prevention of infections
US8480559B2 (en) 2006-09-13 2013-07-09 C. R. Bard, Inc. Urethral support system
DE102006062140A1 (de) * 2006-12-22 2008-06-26 Dow Wolff Cellulosics Gmbh Celluloseetheradditive für die Extrusion keramischer Massen
US20080161405A1 (en) * 2006-12-29 2008-07-03 Erning Xia Biguanide Composition and Method of Treatment and Prevention of Infections
US8206280B2 (en) 2007-11-13 2012-06-26 C. R. Bard, Inc. Adjustable tissue support member
DE102007059939A1 (de) 2007-12-12 2009-06-18 Müller-Schulte, Detlef, Dr. Auflösbare, magnetische und unmagnetische Polymerträger zur Abtrennung und Wiedergewinnung von Zellen und Biosubstanzen
US8449573B2 (en) 2008-12-05 2013-05-28 Boston Scientific Scimed, Inc. Insertion device and method for delivery of a mesh carrier
US8968334B2 (en) 2009-04-17 2015-03-03 Boston Scientific Scimed, Inc. Apparatus for delivering and anchoring implantable medical devices
US9301750B2 (en) 2009-11-03 2016-04-05 Boston Scientific Scimed, Inc. Device and method for delivery of mesh-based devices
GB201105408D0 (en) * 2011-03-30 2011-05-11 Glaxo Group Ltd Composition
CN105358133B (zh) * 2013-07-17 2017-04-26 陶氏环球技术有限责任公司 用于施加到粘膜的包含羟烷基甲基纤维素的组合物
US20160228559A1 (en) * 2013-09-25 2016-08-11 Dow Global Technologies Llc Composition for application to a mucosa comprising a cellulose ether
CN107405303A (zh) * 2015-03-24 2017-11-28 陶氏环球技术有限责任公司 聚合物的水溶液
MA43574A (fr) 2015-08-05 2018-11-14 Childrens Medical Center Compositions ayant des amplificateurs de perméation pour l'administration de médicaments
KR20190053215A (ko) * 2016-09-14 2019-05-17 칠드런'즈 메디컬 센터 코포레이션 약물 전달을 위한 침투 증진제를 함유하는 조성물

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
US3767788A (en) * 1970-06-08 1973-10-23 Burton Parsons Chemicals Inc Ophthalmic solution
SE403782B (sv) * 1973-03-14 1978-09-04 Mo Och Domsjoe Ab Nonjoniska cellulosaetrar
US4001211A (en) * 1974-12-02 1977-01-04 The Dow Chemical Company Pharmaceutical capsules from improved thermogelling methyl cellulose ethers
CS180191B1 (en) * 1974-12-04 1977-12-30 Arnost Kotik Tube shape heat exchanger with internal ribbing
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136178A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3700681A1 (de) * 1987-01-12 1988-07-21 Breveteam Sa Sphaerisches faseraggregat, insbesondere als fuell- oder polstermaterial
US5279660A (en) * 1988-05-24 1994-01-18 Berol Nobel Stenungsund Ab Use of viscosity-adjusting agent to counteract viscosity decrease upon temperature increase of a water-based system
SE461396B (sv) * 1988-05-24 1990-02-12 Berol Kemi Ab Saett att vid temperaturhoejning motverka viskositetsnedgaang alternativt aastadkomma viskositetsoekning hos ett vattenbaserat system innehaallande en polymer som viskositetsgivare
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5306501A (en) * 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5124151A (en) * 1990-08-07 1992-06-23 Mediventures Inc. Drug delivery by injection with thermo-irreversible gels
US5077033A (en) * 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
SE466134B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
US5212162A (en) * 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5296228A (en) * 1992-03-13 1994-03-22 Allergan, Inc. Compositions for controlled delivery of pharmaceutical compounds
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5470881A (en) * 1993-09-09 1995-11-28 West Virginia University Research Corporation Urea ophthalmic ointment and solution

Also Published As

Publication number Publication date
DK0725628T3 (da) 2001-12-27
US5618800A (en) 1997-04-08
PT725628E (pt) 2002-03-28
CN1134662A (zh) 1996-10-30
CA2172373C (en) 1999-03-16
HK1012558A1 (en) 1999-08-06
CA2172373A1 (en) 1996-03-07
CN1162148C (zh) 2004-08-18
EP0725628B1 (de) 2001-11-07
ES2162638T3 (es) 2002-01-01
WO1996006597A1 (en) 1996-03-07
EP0725628A1 (de) 1996-08-14
AU686455B2 (en) 1998-02-05
MX9601591A (es) 1997-05-31
TW460288B (en) 2001-10-21
DE69523733D1 (de) 2001-12-13
ATE208186T1 (de) 2001-11-15
JPH09508143A (ja) 1997-08-19
AU3496595A (en) 1996-03-22

Similar Documents

Publication Publication Date Title
DE69523733D1 (de) Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten
WO1997005185A3 (en) Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
DE69803940T2 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
BR9104280A (pt) Composicao farmaceutica e processo para a preparacao de uma composicao
TW224428B (de)
HU76547A2 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
CA2285180A1 (en) Intravaginal drug delivery system and discharge collection device
TWI262797B (en) Gelling ophthalmic compositions containing xanthan gum
KR900001362A (ko) 마이크로-입자 및/또는 나노-입자로 구성된 신규한 고체 다공성 단위형태 및 그것의 제조
GR3036622T3 (en) Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
DE69102140T2 (de) Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
FI956014A (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
AU5242701A (en) Wound gels
ZA87255B (en) Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension
CA2230595A1 (en) Bioresorbable polymer use in cochlear and other implants
GR3033301T3 (en) Medicament form for the delivery of active substances to wounds
ES2097887T3 (es) Polimero de carboxivinilo con viscosidad newtoniana.
ATE191845T1 (de) Pharmazeutische träger zur topischen ophthalmischen anwendung
FR2757064B1 (fr) Lentille intraoculaire contenant un medicament relargable
WO1995016435A3 (en) Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
BR9707083A (pt) Formas sólidas de administração com liberação instantánea e processos para a sua produção
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
WO1997006769A3 (de) Pharmazeutisches präparat mit trypanoziden eigenschaften enthaltend diminazen, pentamidin und phenazon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition